1. Negotiations continue in the United States on a bill on new stimulus measures
2. One of the participants in the vaccine trials for COVID-19 died
3. Epidemiological conditions continue to deteriorate in Germany
On Wednesday, Nancy Pelosi and Treasury Secretary Steven Mnuchin reported progress in negotiations on a new $2 trillion stimulus package. At the same time, Pelosi said that even if the negotiations are successful, the bill will not have time to be adopted before the presidential election, scheduled for November 3. The likelihood of rapid adoption of the law is reduced due to lack of time and protest in the Republican Party-controlled Senate.
Globo reported that one of the participants in the trials of the coronavirus vaccine, which is being developed by AstraZeneca together with Oxford University, died in Brazil. A 28-year-old Brazilian doctor who decided to voluntarily take part in the vaccine trial died on October 15. The cause of death was complications due to COVID-19.
Meanwhile, in Germany on Wednesday, a record daily increase in the incidence of COVID-19 was recorded - 11,287 people. On the same day, 30 people died of the disease. Data indicate that the epidemiological situation in Germany continues to deteriorate and the authorities may tighten quarantine measures, which will inevitably lead to a decrease in economic activity in the country. Today, Gfk published data on the consumer climate index in Germany. For the month, the indicator decreased from -1.7 to -3.1 points.
News to pay attention today:
09:25 GMT. UK: statement by Bank of England Governor Andrew Bailey
12:30 GMT. US: Weekly Report on the Number of Primary Applications for Unemployment Benefits
14:00 GMT. US: Secondary Housing Market Sales Report